rs1064498

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_002872.5(RAC2):​c.477T>C​(p.Ala159Ala) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.156 in 1,612,120 control chromosomes in the GnomAD database, including 22,937 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.22 ( 4567 hom., cov: 31)
Exomes 𝑓: 0.15 ( 18370 hom. )

Consequence

RAC2
NM_002872.5 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: -0.935

Publications

16 publications found
Variant links:
Genes affected
RAC2 (HGNC:9802): (Rac family small GTPase 2) This gene encodes a member of the Ras superfamily of small guanosine triphosphate (GTP)-metabolizing proteins. The encoded protein localizes to the plasma membrane, where it regulates diverse processes, such as secretion, phagocytosis, and cell polarization. Activity of this protein is also involved in the generation of reactive oxygen species. Mutations in this gene are associated with neutrophil immunodeficiency syndrome. There is a pseudogene for this gene on chromosome 6. [provided by RefSeq, Jul 2013]
RAC2 Gene-Disease associations (from GenCC):
  • immunodeficiency 73b with defective neutrophil chemotaxis and lymphopenia
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, ClinGen
  • immunodeficiency 73c with defective neutrophil chemotaxis and hypogammaglobulinemia
    Inheritance: AR Classification: STRONG, MODERATE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), ClinGen, Ambry Genetics
  • neutrophil immunodeficiency syndrome
    Inheritance: Unknown, AD Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Orphanet, Ambry Genetics, ClinGen, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.74).
BP6
Variant 22-37226775-A-G is Benign according to our data. Variant chr22-37226775-A-G is described in ClinVar as [Benign]. Clinvar id is 138864.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.935 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.389 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
RAC2NM_002872.5 linkc.477T>C p.Ala159Ala synonymous_variant Exon 6 of 7 ENST00000249071.11 NP_002863.1 P15153A0A024R1P2V9H0H7

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
RAC2ENST00000249071.11 linkc.477T>C p.Ala159Ala synonymous_variant Exon 6 of 7 1 NM_002872.5 ENSP00000249071.6 P15153

Frequencies

GnomAD3 genomes
AF:
0.218
AC:
33043
AN:
151414
Hom.:
4554
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.394
Gnomad AMI
AF:
0.157
Gnomad AMR
AF:
0.133
Gnomad ASJ
AF:
0.202
Gnomad EAS
AF:
0.293
Gnomad SAS
AF:
0.120
Gnomad FIN
AF:
0.150
Gnomad MID
AF:
0.244
Gnomad NFE
AF:
0.144
Gnomad OTH
AF:
0.212
GnomAD2 exomes
AF:
0.164
AC:
41061
AN:
250422
AF XY:
0.159
show subpopulations
Gnomad AFR exome
AF:
0.403
Gnomad AMR exome
AF:
0.0912
Gnomad ASJ exome
AF:
0.201
Gnomad EAS exome
AF:
0.298
Gnomad FIN exome
AF:
0.148
Gnomad NFE exome
AF:
0.146
Gnomad OTH exome
AF:
0.172
GnomAD4 exome
AF:
0.150
AC:
219192
AN:
1460588
Hom.:
18370
Cov.:
33
AF XY:
0.148
AC XY:
107765
AN XY:
726634
show subpopulations
African (AFR)
AF:
0.397
AC:
13289
AN:
33450
American (AMR)
AF:
0.0992
AC:
4432
AN:
44656
Ashkenazi Jewish (ASJ)
AF:
0.199
AC:
5202
AN:
26100
East Asian (EAS)
AF:
0.285
AC:
11327
AN:
39690
South Asian (SAS)
AF:
0.105
AC:
9016
AN:
86250
European-Finnish (FIN)
AF:
0.148
AC:
7839
AN:
53074
Middle Eastern (MID)
AF:
0.197
AC:
1136
AN:
5762
European-Non Finnish (NFE)
AF:
0.141
AC:
156150
AN:
1111282
Other (OTH)
AF:
0.179
AC:
10801
AN:
60324
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.466
Heterozygous variant carriers
0
10602
21204
31806
42408
53010
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
5758
11516
17274
23032
28790
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.218
AC:
33092
AN:
151532
Hom.:
4567
Cov.:
31
AF XY:
0.216
AC XY:
16007
AN XY:
74048
show subpopulations
African (AFR)
AF:
0.394
AC:
16230
AN:
41156
American (AMR)
AF:
0.132
AC:
2021
AN:
15254
Ashkenazi Jewish (ASJ)
AF:
0.202
AC:
700
AN:
3468
East Asian (EAS)
AF:
0.292
AC:
1502
AN:
5138
South Asian (SAS)
AF:
0.122
AC:
585
AN:
4812
European-Finnish (FIN)
AF:
0.150
AC:
1585
AN:
10532
Middle Eastern (MID)
AF:
0.255
AC:
75
AN:
294
European-Non Finnish (NFE)
AF:
0.144
AC:
9802
AN:
67860
Other (OTH)
AF:
0.213
AC:
449
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1227
2454
3681
4908
6135
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
326
652
978
1304
1630
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.156
Hom.:
1560
Bravo
AF:
0.227
Asia WGS
AF:
0.219
AC:
760
AN:
3478
EpiCase
AF:
0.150
EpiControl
AF:
0.153

ClinVar

Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:3
Mar 28, 2016
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency -

Jan 07, 2013
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Jan 24, 2024
Unidad de Genómica Garrahan, Hospital de Pediatría Garrahan
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is classified as Benign based on local population frequency. This variant was detected in 21% of patients studied by a panel of primary immunodeficiencies. Number of patients: 20. Only high quality variants are reported. -

Neutrophil immunodeficiency syndrome Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.74
CADD
Benign
8.7
DANN
Benign
0.65
PhyloP100
-0.94
Mutation Taster
=95/5
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1064498; hg19: chr22-37622815; COSMIC: COSV50773917; API